Financhill
Back

Exact Sciences Quote, Financials, Valuation and Earnings

Sell
48

EXAS
Exact Sciences

Last Price:
51.97
Seasonality Move:
17.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Exact Sciences Price Quote

$51.97
-1.37 (-2.57%)
(Updated: May 16, 2024 at 6:50 PM ET)

Exact Sciences Key Stats

Sell
48
Exact Sciences (EXAS) is a Sell

Day range:
$52.91 - $55.14
52-week range:
$52.25 - $100.77
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.83
P/B ratio:
3.14%

Volume:
2.8M
Avg. volume:
2.9M
1-year change:
-34.09%
Market cap:
$9.8B
Revenue:
$2.5B
EPS:
$-1.32

How Much Does Exact Sciences Make?

Is Exact Sciences Growing As A Company?

  • What Is Exact Sciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.06%
  • What Is Exact Sciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Exact Sciences Stock Price Performance

  • Did Exact Sciences Stock Go Up Last Month?
    Exact Sciences share price went down by -18.38% last month
  • Did EXAS's Share Price Rise Over The Last Year?
    EXAS share price fell by -34.09% over the past 1 year

What Is Exact Sciences 52-Week High & Low?

Exact Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Exact Sciences?

  • How Much Debt Does Exact Sciences Have?
    Total long term debt quarterly is $2.4B
  • How Much Cash Does Exact Sciences Have?
    Cash and short term investments quarterly total is $652.1M
  • What Is Exact Sciences’s Book Value Per Share?
    Book value per share is 17.04

Is Exact Sciences Cash Flow Positive?

  • What Is EXAS Cash Flow From Operations?
    Cash flow from operations (TTM) is $112M
  • What Is Exact Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $23.2M
  • What Is Exact Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$204.7M

Exact Sciences Return On Invested Capital

  • Is Management Doing A Good Job?
    EXAS return on invested capital is -4.4%
  • What Is Exact Sciences Return On Assets?
    ROA measures how assets are converting to revenues and is -3.76%
  • What Is EXAS Return On Equity?
    ROE is a measure of profitability and is -7.74%

Exact Sciences Earnings Date & Stock Price

Exact Sciences Competitors

  • Who Are Exact Sciences's Competitors?
    Below is a list of companies who compete with Exact Sciences or are related in some way:
    • Castle Biosciences Inc (CSTL)
    • Quest Diagnostics Inc (DGX)
    • Guardant Health Inc (GH)
    • Illumina Inc (ILMN)
    • Natera Inc (NTRA)

Exact Sciences Dividend Yield

Data Unavailable

Exact Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -32.36%
Revenue: 5.82% 1.71%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 86.59
Upside from Last Price: 62.34%

Major Shareholders

  • How many EXAS shares are owned by institutional investors?
    245.8M EXAS shares are owned by institutional investors
  • How many EXAS shares are owned by insiders?
    4.3M EXAS shares are owned by insiders